<DOC>
	<DOCNO>NCT01024504</DOCNO>
	<brief_summary>This trial evaluate efficacy safety capecitabine oxaliplatine plus bevacizumab combination first-line treatment elderly patient metastatic colorectal cancer .</brief_summary>
	<brief_title>Capecitabine Plus Oxaliplatin Plus Bevacizumab First-line Treatment Elderly Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description>Capecitabine , oxaliplatin bevacizumab well know active agent treatment mCRC . The treatment elderly patient mCRC area investigation . The role comprehensive geriatric assessment treatment efficacy tolerance area investigation .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Histologically cytologically confirm adenocarcinoma colon rectum Stage IV Existence twodimensional measurable disease . The measurable disease irradiate . Absence irradiate stable central nervous system metastatic disease . Life expectancy 3 month . Age ≥ 70 year . Performance status ( WHO ) ≤ 2 . Adequate bone marrow function ( Absolute neutrophil count &gt; 1000/mm3 , Platelet count &gt; 100000/mm3 , Hemoglobin &gt; 9gr/mm3 ) . Adequate liver ( Bilirubin &lt; 1.5 time upper limit normal SGOT/SGPT &lt; 2 time upper limit normal ) . Creatinine clearance ( CockcroftGault formula ) &gt; 30ml/min . No invasive malignancy within past 5 year except nonmelanoma skin cancer . Presence reliable care giver . Informed consent . Prior chemotherapy metastatic disease . History thromboembolic disease myocardial infraction within last 6 month . Peripheral neuropathy ≥ grade 2 . Bowel obstruction chronic diarrhea . Psychiatric illness social situation would preclude study compliance . Other concurrent uncontrolled illness . Other concurrent investigational agent .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Colorectal cancer</keyword>
	<keyword>Elderly</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>Bevacizumab</keyword>
</DOC>